For decades, the medical world has avidly searched for groundbreaking treatments against one of humanity’s most resilient ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

While Parkinson’s disease (PD) has a large and highly generalised therapeutic ... dominating the market due to their efficacy ...

The purchase is the latest in a slew of efforts to invest in its neuroscience portfolio as Humira faces generic competition.

Clinical trials suggest that the drugs seem to treat a host of other conditions, too, including addiction, Parkinson’s ...

People are spending thousands of dollars on unproven exosome therapies for hair loss, skin aging, and acne, as well as more serious conditions like long covid and Alzheimer’s.

What is ageing? Ageing is a highly complex biological process. Our DNA is constantly being broken down and repaired. An ...

Data of Blarcamesine confirm upstream SIGMAR1 activationPresented as Late Breaking Oral Communications at Clinical Trials on Alzheimer’s Disease ...

STOCKHOLM, SE / ACCESSWIRE / October 30, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases aff ...

Olfactory dysfunction links to 139 conditions, with inflammation playing a key role in memory decline and cognitive issues.